Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hyperandrogenism × bicalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 9 Breast Neoplasms 2 Polycystic Ovary Syndrome 1 Neoplasm Metastasis 1 Metabolic Diseases 1 Hyperandrogenism 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Metformin 2 drospirenone and ethinyl estradiol combination 1 bicalutamide 1 Ultrasonography 1 Topiramate 1 Spironolactone 1 Progesterone 1 Ovidrel 1 Hematologic Tests 1 Ethinyl Estradiol 1 Dexamethasone 1 Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05647356 2022-12-12

REFUEL PCOS

Royal College of Surgeons, Ireland

Phase NA Unknown

Metabolic Diseases, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡